UBS Group
ACGN

UBS Group’s Aceragen Inc ACGN Stock Holding History

UBS Group’s Portfolio ACGN Stock Details ACGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-74
Closed -$34K – 8645
2015
Q3 		$34K Buy
+74
New +$32.7K ﹤0.01% 6185

Other funds holding ACGN

PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return

UBS Group's ACGN Position: Q3 2023 in Review

UBS Group sold out of Aceragen Inc (ACGN) in Q3 2023, closing a stake of 1,709 shares — an estimated $2.79K sold.

UBS Group first reported a position in ACGN in Q4 2014 and held it in 35 quarters. The position peaked at $179K in Q2 2018. 3 funds tracked by Wall St. Rank hold ACGN as of Q3 2023.

  • UBS Group reported no remaining Aceragen Inc position as of Q3 2023 after selling out during the quarter.
  • UBS Group sold 1,709 Aceragen Inc shares in Q3 2023, an estimated $2.79K.
  • UBS Group first reported a position in Aceragen Inc in Q4 2014 and held it in 35 quarters.
  • UBS Group's Aceragen Inc position peaked at $179K in Q2 2018.
  • 3 funds tracked by Wall St. Rank held Aceragen Inc as of Q3 2023.

Based on UBS Group's 13F filing for Q3 2023, filed 9 Nov 2023.